NBM History

NBMolecules® SurfLink® technology has been developed over a period of 12 years by a multidisciplinary team from a number of renowned academic institutions including the University of Geneva (‘UniGe’), Ecole Polytechnique Fédérale de Lausanne (‘EPFL’), the University of Zürich and the University of Bern. This collaboration has given rise to a highly sophisticated surface treatment technology which offers a range of benefits not found in any other single surface treatment.

NBMolecules® SurfLink® technology is protected by patents owned by the UniGe and EPFL. According to a license agreement entered into with UniGe and EPFL, the university spin-off company NBMolecules®, established in 2002, owns the worldwide exclusive right to full and unrestricted use, development and exploitation of the technology.

In 2008 NBMolecules® established new laboratories and an office in Canton de Vaud, Switzerland. A small core team manages the company's day to day business. Over 65 contracts with research institutions and other external service providers have been established, and the company continues to grow.

  • 1995-2001
    Proof of concept – in vitro studies
  • 2001
    Patent protection
  • 2002
    Company founded: Spin-off EPFL and University of Geneva
  • 2002-2007
    Verification in small animal study
  • 2007
    ISO 13485 production
  • 2007-2009
    Verification in large animal study
  • 2008 (ongoing)
    Validation in humans
  • 2011 and 2013
    CE-mark for two SurfLink® products
  • 2013
    Technology Innovation Leadership Award by Frost & Sullivan
    Logo Frost &: Sullivan Award 2013
  • 2014
    SurfLink® Dental kit presented at the European Association of Osseointegration conference in Rome
  • 2015
    MIS® Implants Technologies and NBMolecules® conclude a License and Supply Agreement for use of the novel technology SurfLink® for treatment of MIS dental implants.
  • 2016
    MIS and NBM presented the 'B+ surface' at MIS global conference in Barcelona. See the video at youtube.